Role of the Lab in HIV AIDS Treatment, Control (1).ppt

ianleiyan09 82 views 35 slides May 19, 2024
Slide 1
Slide 1 of 35
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35

About This Presentation

I'm studying Clinical Medicines


Slide Content

Module 10.1
Role of the Laboratory in HIV/AIDS
Treatment, Control & Prevention
KMTC Machakos

Envelope
Core
RT

Laboratory Diagnosis of HIV
Infection
CDC
Group I
CDC
Group II/III
CDC
Group IV
(Weeks) (Years)
Window period
InfectionTime
Level
Serological markers of HIV infection
p24 antigen
p24 antigen
IgM antibody
gp41 antibody (IgG)
p24 antibody (IgG)

Laboratory Diagnosis
Diagnosis is important for
prevention of spread
Care efforts
Short course of ART decreases spread from infected
mothers to infants
In tuberculosis patients knowledge of and therapy for
HIV can decrease morbidity

EIA/Western Blot
Viral Culture
p24 antigen Detection
DNA PCR
RT PCR
Rapid antibody tests
Assay Development Chronology
1980
1985
1990
1995
2000

Detection of anti-HIV antibodies
Objectives:
Transfusion
Surveillance
Diagnosis

Antibody Detection by ELISA
Important screening assay
easy
useful for large sample numbers
highly sensitive and specific
useful for blood product screening
useful for diagnosing and monitoring patients
useful for determining disease prevalence
useful for research

Antibody Detection
i) Simple/Rapid Tests
Common in small laboratories and small HIV
testing centres esp VCT, PITC, PMTC,etc
Uses following method
Agglutination
Immunofiltration
Immunochromatographic

Benefits of HIV Rapid Testing
Sensitivity and specificity equal to ELISA
No electricity or machinery
No highly skilled technical staff
Whole blood, plasma, or serum
Very small amounts of blood suitable for
finger prick
Provision of same day/same hour results
Inbuilt controls

Assessment and Comparison of Suitability of Rapid
HIV Test Kits in Small Laboratories
Sensitivity 98 –99%
<98%
3
1
Specificity >98%
95 -98%
3
1
Incubation Room temp.
Other temp.
3
1
Shelf life >1 year
6 months –1 year
3
1
Storage temperature Ambient –RT
Refrigeration 2-8
o
C
3
1
Price/test (USD) <1.0
1 –2
3
2
Ease of performance Easy
Less easy
3
2
Time to complete test <10 min
10 –45 min
3
2
Washer required No
Yes
3
1
Reader required No
Yes
3
1
Score

Definitions
Sensitivity –ability of the test method to detect correctly sample
that contains HIV antibody, a/a+c, expressed as percentage
Specificity-abilityofthetestmethodtodetectcorrectlysamplethat
donotcontainantibodytoHIV,d/b+d,expressedaspercentage
Positivepredictivevalue(PPV)–theprobabilitythatwhenthetest
isreactive,thespecimendoescontainantibodytoHIV,a/a+b
Negativepredictivevalue(NPV)–theprobabilitythatwhenthe
testisnegative,thespecimendoesnotcontainantibodytoHIV,
d/c+d
Note:PredictivevaluesvarywithprevalenceofHIVinthe
population
Reference method
+ - Total
+ a (true pos) b (false pos) b + b
- C (false neg) D (true neg) C + d
Total A + c B + d N (a + b + c + d)
Test method

Antibody Detection
Screening tests
ii) EIA (long ELISA)
Most commonly used in big laboratories
Now at 4
th
generation tests-sensitivity and specificity
very good
Solid phase coated with recombinant antigens and/or
peptides and similar antigens conjugated to a
detecting enzyme
IgG and IgM detected (detection of IgM may reduce
the 2-4 week window period)
Antigens used are mixtures of HIV-1and HIV-2

Antibody Detection
Confirmatorytests
WesternBlot
GoldStandard
Electrophoreticseparationofantigens
Specificantibodiestoeachviralantigen
IndirectImmunofluorescentAntibodyAssay(IFA)
FluorescentmicroscopytovisualizeHIVinfectedcells.
PolymeraseChainreaction(PCR)
DNasequencingofgenes

Western Blot Testing
Confirmatory test
Antibody profile given to a number of Ag
Viral lysate separated into components by
PAGE electrophoresis

PCR
Polymerase chain reaction
can amplify small amounts of viral nucleic acid so they can
be detected by hybridization with nucleic acid probes
mononuclear cells from patient separated by ficoll hypaque
gradient centrifugation
cells are then lysed and double stranded DNA is separated
into single strands
primers are added which are specific for viral DNA
addition of DNA polymerase and nucleotides causes
amplification of viral DNA
alternately heated and cooled to allow for
amplification, dissociation reannealing with primers
and amplification etc again 30 cycles

PCR
Polymerase chain reaction
can amplify small amounts of viral nucleic acid so they can
be detected by hybridization with nucleic acid probes
mononuclear cells from patient separated by ficoll hypaque
gradient centrifugation
cells are then lysed and double stranded DNA is separated
into single strands
primers are added which are specific for viral DNA
addition of DNA polymerase and nucleotides causes
amplification of viral DNA
alternately heated and cooled to allow for
amplification, dissociation reannealing with primers
and amplification etc again 30 cycles

Evaluation of PCR Testing
Very sensitive
can detect non replicating viral genomes
1-2 ml only needed so ideal for newborns
useful in window period
useful for typing HIV-1 and HIV-2
false positives if carry over from previous samples
if Ab negative but PCR positive repeat PCR
not used for routine screening
used in therapy efficacy measurements

Testing of Neonates
IgGs in baby are from mother for first few months
and don’t indicate infection
Most infants from HIV positive mothers will initially
test positive –using antibody detection
Not sensitive in first 3 months of life
p24 Ag detection after disrupting Ag-Ab complexes
with dilute HCl
PCR testing -some positive by 38 days, most not
positive until 6 months –Most recommended

ELISA
Schematic Presentation
HIV antigens
Solid phase
(Well)
Antibodies to HIV
(From the sample)
Enzyme
Conjugate
Stop solution
Formation of specific antigen/antibody complex
Base for enzyme (peroxidase) activity
Hydrogen peroxide for enzyme to digest and produce colour
Stops enzyme activity and changes colour
Colour intensity read by spectrophotometer
Substrate
(Colour reagent)

Specimen Handling for ELISA
Test procedure will indicate whether serum,
plasma, or both can be used for testing
Most kits recommend
Separating the serum/plasma from the red
cells shortly after collection
Specific time that the specimen can be
stored at 2-8
o
Mixing thawed specimens well before use

Quality Control for ELISA
Technique
Use: Negative Controls
1 HIV-1 Pos. Control
1 HIV-2 Pos. Control
1 HIV-1 Group O Pos. Control
Mix specimens and controls well before use
Adhere to incubation times and temperatures
Avoid splashing liquids from 1 well to another
Neg. Control readings must be below the Negative
Cutoff Value
Pos. Control readings must be above the specified
value for the kit

sensitive
Report Consider +ve
A
+ve-ve
specificB
+ve-ve
sensitiveA
+ve-ve
Report
IndeterminateReport
sensitiveC
+ve-ve
+ --
Low risk
A
+ve-ve
sensitive
specificB
+ve-ve
Report
Report
TRANSFUSION
TRANSFUSION
SURVEILLANCE
DIAGNOSIS
DIAGNOSIS
I II III
WHO HIV Antibody Testing Strategies
+ -+
High risk
Sensitivity >97%
Specificity >95%
SERIAL TESTING
PARALLEL TESTING

Determine Assay
Test Principle
HIV-1 & HIV-2 antigens
Lateral flow
Test Components
Test Pads
Desiccant
Instruction manual
Chase Buffer (Whole Blood)

Testing kit

Pull off protective foil

Blood Sample 50ul

Chase Buffer

Results
Reactive 2 lines of any intensity appear in
both the control and patient areas.
Non-reactive 1 line appears in the control area
and no line in the patient area.
Invalid No line appears in the control area.
Do not report invalid results. Repeat test with a new test device even if a
lineappears in the patient area.

PATIENT CONTROL
HIV
-
1/2
472U100
7A
Ab (POS)
or
No Ab (NEG)
Solution
P
Ag/Ab complex
Lateral Flow –Schematic Presentation
Sample pad
Selenium
Conjugate
Colour reagent HIVAg
Anti-human
immunoglobulins
C
C
No reaction
Client #
Client #
7A
PATIENT CONTROL
HIV
-
1/2
472U100P

Unigold Lab workers Health workers Counselors
4
Uni-Gold: Collecting Specimen
3. Collect specimen using the disposable pipette

Unigold TestingLab workers Health workers Counselors
5
Uni-Gold: Adding Specimen and
Reagent to Test Device
4. Add 2 drops (approx. 60µl) of
specimen to the sample port in
the device
5. Add 2 drops (approx. 60µl) of the
appropriate wash reagent to sample
port

Wait for reactionLab workers Health workers Counselors
6
Uni-Gold: Getting Results
6. Wait for 10 minutes (no longer than
20 min.) before reading the results
7. Read and record the results and
other pertinent info on the worksheet

Unigold ResultsLab workers Health workers Counselors
7
Uni-Gold: Test Interpretation
Reactive InvalidNon-reactive

Any questions?

THANK YOU